Effects of amifostine in a patient with an advanced-stage myelodysplastic syndrome


 We report on a 63-year-old man with myelodysplastic syndrome at the stage of a refractory anemia with an excess of blasts in transformation (MDS-RAEB-T), first diagnosed in December 1996. After a period of stability, with no need for transfusions, the MDS progressed into acute myeloid leukemia (AML) in August 1998 with the emergence of a cytogenetic… (More)
DOI: 10.1007/s002770000224


2 Figures and Tables